Caladrius Biosciences, Inc. (CLBS)
(Delayed Data from NSDQ)
$2.94 USD
+0.09 (2.98%)
Updated May 3, 2019 04:00 PM ET
After-Market: $2.97 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$2.94 USD
+0.09 (2.98%)
Updated May 3, 2019 04:00 PM ET
After-Market: $2.97 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Do Options Traders Know Something About Caladrius (CLBS) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Caladrius (CLBS) stock based on the movements in the options market lately.
Caladrius Biosciences, Inc. (CLBS) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Caladrius Biosciences, Inc. (CLBS) delivered earnings and revenue surprises of 33.33% and -100.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for May 27th
by Zacks Equity Research
AFYA, BNL, CLBS, EKSO, and LLY have been added to the Zacks Rank #5 (Strong Sell) List on May 27, 2021
Caladrius Biosciences, Inc. (CLBS) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Caladrius Biosciences, Inc. (CLBS) delivered earnings and revenue surprises of -111.11% and -100.00%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Is the Options Market Predicting a Spike in Caladrius Biosciences (CLBS) Stock?
by Zacks Equity Research
Investors need to pay close attention to Caladrius Biosciences (CLBS) stock based on the movements in the options market lately.
Caladrius Biosciences, Inc. (CLBS) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Caladrius Biosciences, Inc. (CLBS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Blueprint Medicines (BPMC) Gets EMA Validation for Ayvakyt in SM
by Zacks Equity Research
The EMA validates Blueprint Medicines' (BPMC) Type II variation marketing authorization application for Ayvakyt to treat advanced systemic mastocytosis.
New Strong Sell Stocks for February 4th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
New Strong Sell Stocks for January 29th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
Yes, You Can Time the Market. Find out How - August 27, 2020
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Timing the Market, Is it Possible? - August 07, 2020
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
How to Time the Markets Like an Investing Pro - July 20, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Implied Volatility Surging for Caladrius Biosciences (CLBS) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Caladrius Biosciences (CLBS) stock based on the movements in the options market lately.
Timing the Market, Is it Possible? - June 26, 2020
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
The Market Timing Secrets No One Talks About - June 05, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Simple Market Timing Strategies That Work - May 12, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
The Truth About Market Timing - March 06, 2020
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
The Keys to Successfully Timing the Markets - February 14, 2020
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
The Market Timing Secrets No One Talks About - January 27, 2020
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Simple Market Timing Strategies That Work - January 07, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Timing the Market, Is it Possible? - November 25, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
When Does Market Timing Actually Work? - November 04, 2019
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
The Market Timing Secrets No One Talks About - October 14, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
The Keys to Successfully Timing the Markets - September 24, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
The Keys to Successfully Timing the Markets - September 04, 2019
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?